Vera Therapeutics Inc Cl A (VERA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 594 | 466 | 879 | 1,236 | N/A |
| Marketable Securities | 162 | 163 | 242 | 266 | N/A |
| Receivables | 1,736 | 2,035 | 1,980 | 1,912 | N/A |
| Other current assets | 909 | 752 | 678 | 291 | 0 |
| TOTAL | $3,866 | $3,928 | $4,114 | $3,999 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 571 | 593 | 617 | 602 | N/A |
| Intangibles | 960 | 1,020 | 1,080 | 1,140 | 0 |
| Other Non-Current Assets | 7,123 | 7,083 | 7,061 | 7,132 | 0 |
| TOTAL | $8,654 | $8,696 | $8,758 | $8,874 | $N/A |
| Total Assets | $12,520 | $12,624 | $12,872 | $12,873 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 67 | 67 | 67 | 247 | N/A |
| Accounts payable and accrued liabilities | 277 | 593 | 393 | 360 | 0 |
| Accrued Expenses | 737 | 573 | 560 | 667 | N/A |
| Other current liabilities | 733 | 959 | 1,120 | 1,402 | N/A |
| TOTAL | $7,537 | $7,745 | $7,297 | $7,342 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 177 | 195 | 213 | 122 | N/A |
| Deferred Revenues | 4,517 | 4,494 | 4,383 | 4,251 | N/A |
| Other Non-Current Liabilities | 4,698 | 4,773 | 4,849 | 4,967 | 0 |
| TOTAL | $4,874 | $4,968 | $5,062 | $5,089 | $N/A |
| Total Liabilities | $12,411 | $12,714 | $12,359 | $12,431 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,480 | N/A | 10,058 | N/A | N/A |
| Common Shares | 1,056 | 1,034 | 1,014 | 1,019 | N/A |
| Retained earnings | -23,101 | -23,186 | -22,516 | -22,872 | N/A |
| Other shareholders' equity | -682 | -680 | -675 | -367 | 0 |
| TOTAL | $108 | $-90 | $513 | $442 | $N/A |
| Total Liabilities And Equity | $12,520 | $12,624 | $12,872 | $12,873 | $0 |